The prognostic score was not related to clinical and tumor characteristics of the CRC patients such as age, sex, education level, family history of CRC, lifetime regular active smoking status, tumor location, cancer stage, lymph node count, chemotherapy, KRAS mutation, BRAF mutation, and MSI status in both study and validation cohort. This evidence concerns the gene KRAS and neoplasm.